@article{Faillie2016,
abstract = {The aim of this article is to discuss the contribution of pharmacoepidemiology to pharmacovigilance in the context of drug safety monitoring. Because this contribution requires a comparison of the approaches and a presentation of their respective merits, we have tried to show that this comparison did not necessarily mean opposing these methods, which would not serve any useful purpose. We wanted to underline the fact that the notion of contribution of one to the other implied a complementarity that we propose to demonstrate. Pharmacovigilance is essentially based on the study of spontaneous reports and the clinical and pharmaceutical analysis of the implication of given drugs in adverse drug reactions. It yields performances that are unequalled to this day when safety warning signs relate to rare adverse events or to drugs that are rarely used, or when the drug-related event has specificities that are not found for other aetiologies. Pharmacoepidemiology for its part, through its population-related studies and the possible use of a comparison group, enables a quantification of risks that is impossible to carry out using spontaneous reporting alone. It also enables the highlighting and quantification of safety signals for events that are frequent and multifactorial, where the role of a drug in individual cases can be difficult to detect, and therefore difficult to identify fromspontaneous reporting. All in all, this is the major contribution of pharmacoepidemiology topharmacovigilance, where it can be said that it complements pharmacovigilance in drug safetymonitoring but in no way could replace it.},
author = {Faillie, Jean Luc and Montastruc, Fran{\c{c}}ois and Montastruc, Jean Louis and Pariente, Antoine},
doi = {10.1016/j.therap.2016.02.015},
isbn = {0040-5957 (Print) 0040-5957 (Linking)},
issn = {19585578},
journal = {Therapie},
keywords = {Drug,Pharmacoepidemiology,Pharmacovigilance,Risk,Surveillance},
mendeley-groups = {DoMINO},
month = {apr},
number = {2},
pages = {211--216},
pmid = {27080840},
publisher = {Elsevier},
title = {{Pharmacoepidemiology and its input to pharmacovigilance}},
url = {https://www-sciencedirect-com.docelec.u-bordeaux.fr/science/article/pii/S0040595716000342},
volume = {71},
year = {2016}
}
@article{RavoireSophie2017,
author = {Ravoire, Sophie and Lang, Marie and Perrin, Elena and Audry, Antoine and Bilbault, Pascal and Chekroun, Michael and Demerville, Lauren and Escudier, Thierry and Gu{\'{e}}roult-Accolas, Laure and Guillot, Caroline and Malbezin, Muriel and Maugendre, Philippe and Micallef, Jo{\"{e}}lle and Molimard, Mathieu and Montastruc, Fran{\c{c}}ois and Pierron, Evelyne and Reichardt, Lionel and Thiessard, Frantz},
doi = {10.1016/j.therap.2016.11.055},
issn = {19585578},
journal = {Therapie},
mendeley-groups = {DoMINO},
month = {feb},
number = {1},
pages = {125--134},
publisher = {Elsevier},
title = {{Int{\'{e}}r{\^{e}}ts et limites des communaut{\'{e}}s virtuelles de patients pour la recherche sur les produits de sant{\'{e}}}},
url = {https://www-sciencedirect-com.docelec.u-bordeaux.fr/science/article/pii/S0040595716312653},
volume = {72},
year = {2017}
}
@article{C.Bousquet2014,
abstract = {INTRODUCTION Les messages des patients dans les forums de discussion sur Internet constituent une source potentielle de connaissance sur les effets ind{\'{e}}sirables susceptibles d'{\^{e}}tre li{\'{e}}s aux m{\'{e}}dicaments. L'auteur de cette communication est le coordinateur du projet Vigi4MED (Vigilance dans les forums sur les m{\'{e}}dicaments) qui a pour objectif d'{\'{e}}valuer l'int{\'{e}}r{\^{e}}t de ces messages pour la d{\'{e}}tection de nouveaux signaux en pharmacovigilance. Les premiers r{\'{e}}sultats {\'{e}}tant attendus en 2015, l'objet de cette pr{\'{e}}sentation est de faire un point sur l'{\'{e}}tat de l'art dans ce domaine {\'{e}}mergent, en pointant les questions qui restent en suspens. M{\'{E}}THODE Recherche bibliographique sur PubMed, Google Scholar et Embase. R{\'{E}}SULTATS Dix-neuf publications d{\'{e}}crivent une approche d'extraction automatis{\'{e}}e des effets ind{\'{e}}sirables suppos{\'{e}}s {\`{a}} partir de pages Web au moyen d'outils informatiques, compl{\'{e}}t{\'{e}}e par une mesure quantitative des effets ind{\'{e}}sirables retrouv{\'{e}}s ; 12 publications rapportent une analyse manuelle des messages des patients dans les forums suivie d'un examen qualitatif de ces messages. Les r{\'{e}}sultats d{\'{e}}montrent que les forums contiennent des donn{\'{e}}es en quantit{\'{e}} et qualit{\'{e}} suffisante pour l'{\'{e}}valuation de certains probl{\`{e}}mes m{\'{e}}dicamenteux {\'{e}}voqu{\'{e}}s dans ces publications. La possibilit{\'{e}} de d{\'{e}}tecter des signaux de pharmacovigilance avant que ces probl{\`{e}}mes ne soient signal{\'{e}}s par les autorit{\'{e}}s de sant{\'{e}} est rarement document{\'{e}}e. DISCUSSION L'information extraite {\`{a}} partir des r{\'{e}}seaux sur Internet pr{\'{e}}sente des probl{\`{e}}mes de fiabilit{\'{e}}. Les patients sont d{\'{e}}sign{\'{e}}s par des pseudonymes, ce qui laisse la porte ouverte pour la diffusion de fausses rumeurs. De plus, il est g{\'{e}}n{\'{e}}ralement impossible de demander des informations compl{\'{e}}mentaires qui permettraient de mieux documenter le cas ou de remonter au prescripteur pour avoir confirmation des faits qui sont d{\'{e}}crits. Il est quand m{\^{e}}me int{\'{e}}ressant de prendre en compte ces messages sur Internet en compl{\'{e}}ment des m{\'{e}}thodes classiques parce que cela permet de mieux tenir compte des probl{\`{e}}mes rapport{\'{e}}s par les patients et il serait regrettable de renoncer {\`{a}} exploiter une nouvelle source de connaissances maintenant disponible. CONCLUSION La possibilit{\'{e}} d'extraire des informations sur Internet {\'{e}}tant possible d'un point de vue technique, il convient de v{\'{e}}rifier comment cette nouvelle source d'information peut s'int{\'{e}}grer dans les syst{\`{e}}mes classiques de pharmacovigilance, qu'il s'agisse de d{\'{e}}tecter, v{\'{e}}rifier ou valider des signaux. Cela d{\'{e}}pendra de la qualit{\'{e}} de l'information recueillie, de sa fiabilit{\'{e}} et de sa nouveaut{\'{e}} par rapport {\`{a}} l'{\'{e}}tat des connaissances sur le m{\'{e}}dicament. REMERCIEMENTS Le projet Vigi4MED est financ{\'{e}} dans le cadre de l'appel {\`{a}} projet 2013 de l'Agence nationale de s{\'{e}}curit{\'{e}} du m{\'{e}}dicament et des produits de sant{\'{e}} (AAP-2013-052). Ce r{\'{e}}sum{\'{e}} pr{\'{e}}sente uniquement les opinions de l'auteur.},
author = {Bousquet, C.},
doi = {10.1016/J.TOXAC.2014.09.013},
issn = {2352-0078},
journal = {Toxicologie Analytique et Clinique},
mendeley-groups = {DoMINO},
month = {dec},
number = {4},
pages = {214--215},
publisher = {Elsevier},
title = {{Veille sanitaire sur internet et sur les r{\'{e}}seaux sociaux–recherche et analyse des effets ind{\'{e}}sirables m{\'{e}}dicamenteux rapport{\'{e}}s par les patients dans les r{\'{e}}seaux sociaux}},
url = {https://www.sciencedirect.com/science/article/pii/S2352007814000870{\#}!},
volume = {26},
year = {2014}
}
@article{France2007,
author = {ANSM},
file = {:C$\backslash$:/Users/fly{\_}r/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Afssaps - Unknown - Glossaire des vigilances 2011.pdf:pdf},
keywords = {Glossaire$\backslash$nVigilances},
mendeley-groups = {DoMINO},
title = {{Glossaire des vigilances}},
url = {https://ansm.sante.fr/var/ansm_site/storage/original/application/669b2151e254e27ff9b48ba1cdabf78f.pdf},
year = {2011}
}
@misc{LegiFrance,
abstract = {Article R5121-152 Modifi{\'{e}} par D{\'{e}}cret n°2013-923 du 16 octobre 2013 - art. 2 Pour l'application du pr{\'{e}}sent chapitre, on entend par : 1° " Effet ind{\'{e}}sirable " : une r{\'{e}}action nocive et non voulue {\`{a}} un m{\'{e}}dicament ou {\`{a}} un produit mentionn{\'{e}} {\`{a}} l'article R. 5121-150 ; 2° " Effet ind{\'{e}}sirable grave " : un effet ind{\'{e}}sirable l{\'{e}}tal, ou susceptible de mettre la vie en danger, ou entra{\^{i}}nant une invalidit{\'{e}} ou une incapacit{\'{e}} importantes ou durables, ou provoquant ou prolongeant une hospitalisation, ou se manifestant par une anomalie ou une malformation cong{\'{e}}nitale ; 3° " Effet ind{\'{e}}sirable inattendu " : un effet ind{\'{e}}sirable dont la nature, la s{\'{e}}v{\'{e}}rit{\'{e}} ou l'{\'{e}}volution ne correspondent pas aux informations contenues dans le r{\'{e}}sum{\'{e}} des caract{\'{e}}ristiques du produit mentionn{\'{e}} {\`{a}} l'article R. 5121-21 ; 4° " M{\'{e}}susage " : une utilisation intentionnelle et inappropri{\'{e}}e d'un m{\'{e}}dicament ou d'un produit, non conforme {\`{a}} l'autorisation de mise sur le march{\'{e}} ou {\`{a}} l'enregistrement ainsi qu'aux recommandations de bonnes pratiques ; 5° " Abus " : un usage excessif intentionnel, persistant ou sporadique, de m{\'{e}}dicaments ou de produits mentionn{\'{e}}s {\`{a}} l'article R. 5121-150, accompagn{\'{e}} de r{\'{e}}actions physiques ou psychologiques nocives ; 6° " Surdosage " : administration d'une quantit{\'{e}} de m{\'{e}}dicament ou de produit, quantit{\'{e}} par prise ou cumul{\'{e}}e sup{\'{e}}rieure {\`{a}} la dose maximale recommand{\'{e}}e par le r{\'{e}}sum{\'{e}} des caract{\'{e}}ristiques du produit mentionn{\'{e}} {\`{a}} l'article R. 5121-1 ; 7° " Etudes de s{\'{e}}curit{\'{e}} post-autorisation " : toute {\'{e}}tude portant sur un m{\'{e}}dicament ou un produit autoris{\'{e}} et visant {\`{a}} identifier, caract{\'{e}}riser ou quantifier un risque relatif {\`{a}} la s{\'{e}}curit{\'{e}}, {\`{a}} confirmer le profil de s{\'{e}}curit{\'{e}} du m{\'{e}}dicament ou {\`{a}} mesurer l'efficacit{\'{e}} des mesures de gestion des risques ; 8° " Etudes d'efficacit{\'{e}} post-autorisation " : toute recherche biom{\'{e}}dicale ou toute {\'{e}}tude observationnelle sur l'efficacit{\'{e}} en pratique m{\'{e}}dicale courante portant sur un m{\'{e}}dicament ou un produit ; 9° " Syst{\`{e}}me de gestion des risques " : un ensemble d'activit{\'{e}}s de pharmacovigilance ayant pour but d'identifier et de d{\'{e}}crire les risques li{\'{e}}s {\`{a}} un m{\'{e}}dicament ou {\`{a}} un produit mentionn{\'{e}} {\`{a}} l'article R. 5121-150 et un ensemble de mesures dont l'objectif est de pr{\'{e}}venir ou de minimiser ces risques, y compris l'{\'{e}}valuation de l'efficacit{\'{e}} desdites activit{\'{e}}s et mesures. Cet ensemble d'activit{\'{e}}s et de mesures est proportionn{\'{e}} aux risques av{\'{e}}r{\'{e}}s et aux risques potentiels du m{\'{e}}dicament ou du produit, ainsi qu'{\`{a}} la n{\'{e}}cessit{\'{e}} de disposer d'informations de s{\'{e}}curit{\'{e}} apr{\`{e}}s l'autorisation de mise sur le march{\'{e}} ; 10° " Plan de gestion des risques " : une description d{\'{e}}taill{\'{e}}e du syst{\`{e}}me de gestion des risques d{\'{e}}fini au 9° ; 11° " Syst{\`{e}}me de pharmacovigilance " : un syst{\`{e}}me mis en place et utilis{\'{e}} par toute entreprise ou tout organisme exploitant un m{\'{e}}dicament ou un produit mentionn{\'{e}} {\`{a}} l'article R. 5121-150 ainsi que par l'Agence nationale de s{\'{e}}curit{\'{e}} du m{\'{e}}dicament et des produits de sant{\'{e}} afin de s'acquitter des obligations qui leur incombent en mati{\`{e}}re de pharmacovigilance et visant {\`{a}} surveiller la s{\'{e}}curit{\'{e}} des m{\'{e}}dicaments ou des produits mentionn{\'{e}}s {\`{a}} l'article R. 5121-150 et {\`{a}} rep{\'{e}}rer toute modification du rapport entre leurs b{\'{e}}n{\'{e}}fices et leurs risques ; 12° " Dossier permanent du syst{\`{e}}me de pharmacovigilance " : une description d{\'{e}}taill{\'{e}}e du syst{\`{e}}me de pharmacovigilance mis en place et utilis{\'{e}} par toute entreprise ou tout organisme exploitant un m{\'{e}}dicament ou un produit mentionn{\'{e}} {\`{a}} l'article R. 5121-150 concernant un ou plusieurs de ces m{\'{e}}dicaments ou de ces produits ; 13° " Erreur m{\'{e}}dicamenteuse " : une erreur non intentionnelle d'un professionnel de sant{\'{e}}, d'un patient ou d'un tiers, selon le cas, survenue au cours du processus de soin impliquant un m{\'{e}}dicament ou un produit de sant{\'{e}} mentionn{\'{e}} {\`{a}} l'article R. 5121-150, notamment lors de la prescription, de la dispensation ou de l'administration ; 14° " Exposition professionnelle " : une exposition {\`{a}} un m{\'{e}}dicament ou {\`{a}} un produit mentionn{\'{e}} {\`{a}} l'article R. 5121-150 dans le cadre de l'activit{\'{e}} professionnelle.},
author = {LegiFrance},
mendeley-groups = {DoMINO},
title = {{Code de la sant{\'{e}} publique - Article R5121-152 | Legifrance}},
url = {https://www.legifrance.gouv.fr/affichCodeArticle.do?idArticle=LEGIARTI000028083982{\&}cidTexte=LEGITEXT000006072665},
urldate = {2018-08-16}
}
@article{DRUGS-SAFEa,
abstract = {La plateforme DRUGS-SAFE (DRUGS Systematized Assessment in real-liFe Environment) a {\'{e}}t{\'{e}} lanc{\'{e}}e en Janvier 2015. Elle est financ{\'{e}}e par l'Agence Nationale de S{\'{e}}curit{\'{e}} du M{\'{e}}dicament et des Produits de Sant{\'{e}} (ANSM) pour une dur{\'{e}}e de quatre ans ; seules deux structures de ce type existent en France. Coordonn{\'{e}}e par le Pr Antoine Pariente, la plateforme DRUGS-SAFE est constitu{\'{e}}e de six {\'{e}}quipes de recherche acad{\'{e}}miques. Cinq de ces {\'{e}}quipes sont affili{\'{e}}es au Centre de Recherche Bordeaux Population Health (l'{\'{e}}quipe Pharmaco-{\'{e}}pid{\'{e}}miologie, les {\'{e}}quipes d'{\'{e}}pid{\'{e}}miologie du Vieillissement, l'{\'{e}}quipe IETO d'accidentologie, les {\'{e}}quipes de Biostatistique, et l'{\'{e}}quipe ERIAS d'informatique appliqu{\'{e}}e {\`{a}} la sant{\'{e}}) ; la sixi{\`{e}}me unit{\'{e}}, localis{\'{e}}e {\`{a}} Marseille, est compos{\'{e}}e par les {\'{e}}quipes de l'UMR 1252 – SESSTIM et de l'ORS PACA. DRUGS-SAFE est con{\c{c}}ue comme un syst{\`{e}}me global d'{\'{e}}valuation du m{\'{e}}dicament tel qu'il est utilis{\'{e}} dans la population. Le programme de travail de la plateforme comprend principalement des {\'{e}}tudes r{\'{e}}alis{\'{e}}es {\`{a}} partir des bases de l'Assurance Maladie, {\'{e}}tudes d'utilisation des m{\'{e}}dicaments d'une part, et {\'{e}}tudes de quantification de risques associ{\'{e}}s {\`{a}} cette utilisation d'autre part. Les informations qu'apportent ces {\'{e}}tudes, ind{\'{e}}pendantes de l'industrie pharmaceutique, servent {\`{a}} orienter les prises de d{\'{e}}cisions concernant le m{\'{e}}dicament et les interventions destin{\'{e}}es {\`{a}} am{\'{e}}liorer son usage. Depuis son lancement en 2015, DRUGS-SAFE a ainsi, entre autres, r{\'{e}}alis{\'{e}} un nouvel {\'{e}}tat des lieux concernant la consommation de psychotropes en France, conduit des {\'{e}}tudes portant sur le risque d'accident de la route ou de traumatismes associ{\'{e}}s {\`{a}} l'utilisation de certains m{\'{e}}dicaments comme les antiallergiques ou les antidiab{\'{e}}tiques. En parall{\`{e}}le de la r{\'{e}}alisation de ces {\'{e}}tudes cibl{\'{e}}es, pour permettre de mieux utiliser les donn{\'{e}}es complexes en sant{\'{e}}, les {\'{e}}quipes contribuant {\`{a}} DRUGS-SAFE d{\'{e}}veloppent de nouveaux outils permettant, par exemple, de palier au manque de certaines donn{\'{e}}es dans les bases de l'Assurance Maladie, ou d'identifier des situations de m{\'{e}}susage du m{\'{e}}dicament {\`{a}} partir des donn{\'{e}}es contenues dans les forums de sant{\'{e}}. Au total, en deux ans, une vingtaine d'{\'{e}}tudes ont {\'{e}}t{\'{e}} conduites dans le cadre de cette plateforme {\`{a}} financement public exclusif. Une quinzaine de personnes sur contrat contribuent {\`{a}} DRUGS-SAFE aux c{\^{o}}t{\'{e}}s des chercheurs universitaires responsables des six {\'{e}}quipes participantes. L'opportunit{\'{e}} de p{\'{e}}renniser ce dispositif d'{\'{e}}valuation du m{\'{e}}dicament, dont le financement et le programme sont assur{\'{e}}s jusqu'en 2018 par la seule ANSM, est en discussion.},
author = {},
mendeley-groups = {DoMINO},
title = {{LA PLATE-FORME DRUGS-SAFE}},
url = {https://drugssafe.fr/plateforme/}
}
@misc{DRUGS-SAFE,
abstract = {Ce projet a pour objectif de r{\'{e}}aliser une analyse des forums de discussion pour retrouver les messages contenant un m{\'{e}}dicament dont l'usage n'est pas celui attendu. Une visualisation graphique permet une navigation rapide vers les probl{\`{e}}mes les plus aigus ou les plus fr{\'{e}}quemment rencontr{\'{e}}s.},
author = {DRUGS-SAFE},
keywords = {Contre-indications,D{\'{e}}tection,Forum de discussion},
mendeley-groups = {DoMINO},
mendeley-tags = {Contre-indications,D{\'{e}}tection,Forum de discussion},
title = {{DoMINO - D{\'{e}}tection du m{\'{e}}susage des m{\'{e}}dicaments dans les forums et r{\'{e}}seaux sociaux – DRUGS-SAFE}},
url = {https://drugssafe.fr/2015/08/17/domino/},
urldate = {2018-08-16}
}
@misc{ANSM,
author = {ANSM},
file = {:C$\backslash$:/Users/fly{\_}r/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/ANSM - Unknown - Validation d'un outil de d{\'{e}}tection de signaux de pharmacovigilance et de m{\'{e}}susage des m{\'{e}}dicaments issus des r{\'{e}}seaux soc.pdf:pdf},
mendeley-groups = {ERIAS/Domino/ANSM,DoMINO},
pages = {2},
title = {{Validation d'un outil de d{\'{e}}tection de signaux de pharmacovigilance et de m{\'{e}}susage des m{\'{e}}dicaments issus des r{\'{e}}seaux sociaux et internet}},
url = {https://www.ansm.sante.fr/content/download/86515/1090687/version/1/file/APPE{\_}02{\_}SocialMedia{\_}2016.pdf}
}
@misc{BPHU1219,
author = {{BPH U1219}},
mendeley-groups = {ERIAS,DoMINO},
title = {{Equipe de recherche en informatique appliqu{\'{e}}e {\`{a}} la sant{\'{e}} – ERIAS}},
url = {https://www.bordeaux-population-health.center/les-equipes/equipe-de-recherche-en-informatique-appliquee-a-la-sante-erias/}
}
@misc{ISPED,
abstract = {En savoir + Dipl{\^{o}}me › Master 2 Mention › Sant{\'{e}} publique Parcours › Syst{\`{e}}mes d'informations et technologies informatiques pour la sant{\'{e}} Conditions d'acc{\`{e}}s › {\'{E}}tudiants en formation initiale ayant valid{\'{e}} :-soit un master 1 de sant{\'{e}} publique, de biologie, d'informatique ou plus g{\'{e}}n{\'{e}}ralement scientifique,-soit un 2 e cycle d'{\'{e}}tudes m{\'{e}}dicales, pharmaceutiques, odontologiques ou ma{\"{i}}eutique, en ayant valid{\'{e}} des UER d'informatique › Adultes en reprise d'{\'{e}}tudes (formation continue) ayant ou ayant eu des activit{\'{e}}s professionnelles en rapport avec la sp{\'{e}}cialit{\'{e}} du dipl{\^{o}}me et :-ayant un dipl{\^{o}}me BAC+4-b{\'{e}}n{\'{e}}ficiant de la validation des acquis professionnels en vigueur {\`{a}} l'universit{\'{e}} de Bordeaux *Etudiant : personne n'ayant jamais interrompu son cursus initial de formation ou l'ayant interrompu depuis moins de deux ans **Adulte en reprise d'{\'{e}}tudes : personne ayant termin{\'{e}} son cursus initial de formation depuis deux ans (soit l'ann{\'{e}}e universitaire 2015/2016) et plus. Modalit{\'{e}}s particuli{\`{e}}res › Formation initiale, formation continue, contrat de professionnalisation, contrat d'apprentissage, VAE-VAP. Dur{\'{e}}e et rythme de la formation › 1 an r{\'{e}}parti en 2 semestres : 15 {\`{a}} 16 semaines en cours, puis 16 {\`{a}} 24 semaines de stage › Formation {\`{a}} plein-temps Rythme de l'alternance (apprenti et contrat pro) › Septembre {\`{a}} janvier : en moyenne, 3 semaines {\`{a}} l'universit{\'{e}}, et 1 semaine en entreprise › F{\'{e}}vrier {\`{a}} juin : en moyenne, 1 semaine {\`{a}} l'universit{\'{e}} et 6 semaines en entreprise › Juillet et Ao{\^{u}}t : temps complet en entreprise Volume horaire › Semestre 3 : 330 heures › Semestre 4 : 70 heures + stage Organisation des enseignements › Selon les UE, enseignements alternant cours int{\'{e}}gr{\'{e}}s, travaux dirig{\'{e}}s, projets et ateliers en groupes › D{\'{e}}finition du sujet de stage et son suivi r{\'{e}}alis{\'{e}}s dans le cadre d'ateliers rassemblant l'ensemble de la promotion et les membres de l'{\'{e}}quipe p{\'{e}}dagogique Organisation de la formation › Possibilit{\'{e}} d'int{\'{e}}grer directement le parcours en master 2 sans faire la premi{\`{e}}re ann{\'{e}}e du master mention sant{\'{e}} publique › Formation th{\'{e}}orique de mi-septembre {\`{a}} mi-f{\'{e}}vrier, suivie d'un stage de 16 {\`{a}} 24 semaines › Soutenance du m{\'{e}}moire fin juin-d{\'{e}}but juillet pour les stages de 16 semaines et en septembre pour les stages de 24 semaines Contr{\^{o}}le des connaissances › Contenu des enseignements organis{\'{e}}s en UE cr{\'{e}}dit{\'{e}}es d'ECTS › Pour l'obtention du dipl{\^{o}}me, validation ou compensation des UE des deux semestres › Pour chaque UE : contr{\^{o}}le de connaissances sp{\'{e}}cifique par le biais d'un contr{\^{o}}le continu (individuel ou en groupe, oral ou {\'{e}}crit) et/ou d'un examen final › Stage donnant lieu {\`{a}} la r{\'{e}}daction d'un m{\'{e}}moire et {\`{a}} une soutenance orale devant un jury Lieu de la formation › Bordeaux Carreire International › Possibilit{\'{e}} de faire le stage {\`{a}} l'{\'{e}}tranger (aide {\`{a}} la mobilit{\'{e}} internationale propos{\'{e}}e localement) Nombre de places › 20 en pr{\'{e}}sentiel Carte d'identit{\'{e}} de la formation Sant{\'{e}} publique Master 2 SITIS Ouvert {\`{a}} l'apprentissage Rubrique FORMATION puis MASTER SANTE PUBLIQUE puis Master 2 SITIS La s{\'{e}}lection des candidats se fait sur dossier incluant un CV d{\'{e}}taill{\'{e}} et une lettre de motivation. Si n{\'{e}}cessaire, un entretien avec le responsable p{\'{e}}dagogique de la formation est organis{\'{e}}. › Retrait des dossiers de candidature {\`{a}} partir du 16 avril › Envoi des dossiers compl{\'{e}}t{\'{e}}s par Internet avant le 15 juin › P{\'{e}}riodes de s{\'{e}}lection, r{\'{e}}ponse en juillet Contacts Responsable p{\'{e}}dagogique › Fleur Mougin Assistante p{\'{e}}dagogique › Barbara Garreau},
author = {ISPED},
file = {:C$\backslash$:/Users/fly{\_}r/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/ISPED - Unknown - Plaquette M2 SITIS, ISPED.pdf:pdf},
keywords = {activit{\'{e}}s de l,adjoint administratif de la,sqep},
mendeley-groups = {ERIAS,DoMINO},
title = {{Plaquette M2 SITIS, ISPED}},
url = {http://www.isped.u-bordeaux.fr/Portals/0/FormationsISPED/Plaquette{\_}M2{\_}SITIS.pdf},
urldate = {2018-08-13}
}
@article{Le2011,
author = {ANSM and Pariente, Antoine},
file = {:C$\backslash$:/Users/fly{\_}r/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Le, Du, Pariente - 2011 - Compte rendu de s{\'{e}}ance Groupe de travail Etudes Epid{\'{e}}miologiques des Produits de Sant{\'{e}} GT272014024.pdf:pdf},
keywords = {ANSM,DRUG-2M,GT272014013 - Etudes epidemiologiques},
mendeley-groups = {ERIAS/Domino/solution pre-existantes/DURG-2M,DoMINO},
mendeley-tags = {ANSM,DRUG-2M},
number = {0},
pages = {1--12},
title = {{Compte rendu de s{\'{e}}ance Groupe de travail Etudes Epid{\'{e}}miologiques des Produits de Sant{\'{e}} GT272014024}},
url = {http://ansm.sante.fr/var/ansm{\_}site/storage/original/application/93fecc4efee6f79eb4455f2961b28441.pdf},
volume = {33},
year = {2011}
}
@article{Bousquet2011,
abstract = {Objectives: Prevention of adverse drug reactions (ADRs) has become an important public health issue. Pharmacovigilance is dedicated to the identification, analysis and prevention of risks related to ADRs. The objective of the VigiTerms project is to develop innovative methods for earlier detection of ADRs. Material and methods: We used methods related to knowledge engineering, multi lingual engineering, natural language processing and text mining. Results: The main result of the project is a software architecture for search and analysis of articles describing ADRs on the PubMed server. This is the first implementation of such an application for pharmacovigilance. Other results are related to statistical signal detection, modelling of drugs and ADRs with ontologies, information retrieval in pharmacovigilance databases and natural language processing applied to case reports in Japanese. Discussion: Developments are underway to make the results of the project in operational form for use by regulatory authorities and pharmaceutical companies. Improved graphical user interface should facilitate decision support for professionals in charge of pharmacovigilance issues. Conclusion: Our ambition is to continue the integration of components on the common platform to offer pharmacovigilance teams the most complete and effective tools for detecting, tracking and consolidation of pharmacovigilance signals. {\textcopyright} 2011 Elsevier Masson SAS. All rights reserved.},
author = {Bousquet, C{\'{e}}dric and Amardheil, F and Daube, J. M. and Delamarre, D. and Duclos, C. and Lanne, S. G. and Jaulent, M. C. and {Lillo-Le Lou{\"{e}}t}, A. and Toussaint, Y.},
doi = {10.1016/j.irbm.2011.01.037},
issn = {19590318},
journal = {IRBM},
keywords = {Information retrieval,Natural language processing,Ontology,Pharmacovigilance,Signal detection},
mendeley-groups = {DoMINO},
month = {apr},
number = {2},
pages = {158--161},
publisher = {Elsevier Masson},
title = {{Vers une meilleure d{\'{e}}tection du signal et gestion des connaissances en pharmacovigilance: Le projet VigiTermes}},
url = {https://www-sciencedirect-com.docelec.u-bordeaux.fr/science/article/pii/S1959031811000509},
volume = {32},
year = {2011}
}
@misc{ANSM2014,
author = {ANSM},
mendeley-groups = {DoMINO},
title = {{L'ANSM soutient deux plateformes en {\'{e}}pid{\'{e}}miologie des produits de sant{\'{e}} - Point d'information - Appel {\`{a}} candidature 2014}},
url = {https://www.ansm.sante.fr/S-informer/Points-d-information-Points-d-information/L-ANSM-soutient-deux-plateformes-en-epidemiologie-des-produits-de-sante-Point-d-information},
urldate = {2018-08-21},
year = {2014}
}
@misc{Huang2014,
abstract = {Post-marketing drug surveillance for adverse drug events (ADEs) has typically relied on spontaneous reporting. Recently, regulatory agencies have turned their attention to more preemptive approaches that use existing data for surveillance. We conducted an environmental scan to identify active surveillance systems worldwide that use existing data for the detection of ADEs. We extracted data about the systems' structures, data, and functions. We synthesized the information across systems to identify common features of these systems. We identified nine active surveillance systems. Two systems are US based-the FDA Sentinel Initiative (including both the Mini-Sentinel Initiative and the Federal Partner Collaboration) and the Vaccine Safety Datalink (VSD); two are Canadian-the Canadian Network for Observational Drug Effect Studies (CNODES) and the Vaccine and Immunization Surveillance in Ontario (VISION); and two are European-the Exploring and Understanding Adverse Drug Reactions by Integrative Mining of Clinical Records and Biomedical Knowledge (EU-ADR) Alliance and the Vaccine Adverse Event Surveillance and Communication (VAESCO). Additionally, there is the Asian Pharmacoepidemiology Network (AsPEN) and the Shanghai Drug Monitoring and Evaluative System (SDMES). We identified two systems in the UK-the Vigilance and Risk Management of Medicines (VRMM) Division and the Drug Safety Research Unit (DSRU), an independent academic unit. These surveillance systems mostly use administrative claims or electronic medical records; most conduct pharmacovigilance on behalf of a regulatory agency. Either a common data model or a centralized model is used to access existing data. The systems have been built using national data alone or via partnership with other countries. However, active surveillance systems using existing data remain rare. North America and Europe have the most population coverage; with Asian countries making good advances.},
author = {Huang, Yu Lin and Moon, Jinhee and Segal, Jodi B.},
booktitle = {Drug Safety},
doi = {10.1007/s40264-014-0194-3},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Huang, Moon, Segal - 2014 - A Comparison of Active Adverse Event Surveillance Systems Worldwide.pdf:pdf},
isbn = {0114-5916},
issn = {11791942},
mendeley-groups = {DoMINO},
month = {aug},
number = {8},
pages = {581--596},
pmid = {25022829},
publisher = {Springer International Publishing},
title = {{A comparison of active adverse event surveillance systems worldwide}},
url = {http://link.springer.com/10.1007/s40264-014-0194-3},
volume = {37},
year = {2014}
}
@article{Sarker2014,
abstract = {Objective: Automatic detection of adverse drug reaction (ADR) mentions from text has recently received significant interest in pharmacovigilance research. Current research focuses on various sources of text-based information, including social media-where enormous amounts of user posted data is available, which have the potential for use in pharmacovigilance if collected and filtered accurately. The aims of this study are: (i) to explore natural language processing (NLP) approaches for generating useful features from text, and utilizing them in optimized machine learning algorithms for automatic classification of ADR assertive text segments; (ii) to present two data sets that we prepared for the task of ADR detection from user posted internet data; and (iii) to investigate if combining training data from distinct corpora can improve automatic classification accuracies. Methods: One of our three data sets contains annotated sentences from clinical reports, and the two other data sets, built in-house, consist of annotated posts from social media. Our text classification approach relies on generating a large set of features, representing semantic properties (. e.g., sentiment, polarity, and topic), from short text nuggets. Importantly, using our expanded feature sets, we combine training data from different corpora in attempts to boost classification accuracies. Results: Our feature-rich classification approach performs significantly better than previously published approaches with ADR class F-scores of 0.812 (previously reported best: 0.770), 0.538 and 0.678 for the three data sets. Combining training data from multiple compatible corpora further improves the ADR F-scores for the in-house data sets to 0.597 (improvement of 5.9 units) and 0.704 (improvement of 2.6 units) respectively. Conclusions: Our research results indicate that using advanced NLP techniques for generating information rich features from text can significantly improve classification accuracies over existing benchmarks. Our experiments illustrate the benefits of incorporating various semantic features such as topics, concepts, sentiments, and polarities. Finally, we show that integration of information from compatible corpora can significantly improve classification performance. This form of multi-corpus training may be particularly useful in cases where data sets are heavily imbalanced (. e.g., social media data), and may reduce the time and costs associated with the annotation of data in the future.},
archivePrefix = {arXiv},
arxivId = {15334406},
author = {Sarker, Abeed and Gonzalez, Graciela},
doi = {10.1016/j.jbi.2014.11.002},
eprint = {15334406},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Sarker, Gonzalez - 2015 - Portable automatic text classification for adverse drug reaction detection via multi-corpus training.pdf:pdf},
isbn = {1532-0464, 1532-0464},
issn = {15320464},
journal = {Journal of Biomedical Informatics},
keywords = {Adverse drug reaction,Natural language processing,Pharmacovigilance,Social media monitoring,Text classification},
mendeley-groups = {DoMINO},
month = {feb},
pages = {196--207},
pmid = {25451103},
publisher = {Academic Press},
title = {{Portable automatic text classification for adverse drug reaction detection via multi-corpus training}},
url = {https://www.sciencedirect.com/science/article/pii/S1532046414002317?via{\%}3Dihub http://linkinghub.elsevier.com/retrieve/pii/S1532046414002317},
volume = {53},
year = {2014}
}
@article{Karimi2015,
abstract = {CSIRO Adverse Drug Event Corpus (C. adec) is a new rich annotated corpus of medical forum posts on patient-reported Adverse Drug Events (ADEs). The corpus is sourced from posts on social media, and contains text that is largely written in colloquial language and often deviates from formal English grammar and punctuation rules. Annotations contain mentions of concepts such as drugs, adverse effects, symptoms, and diseases linked to their corresponding concepts in controlled vocabularies, i.e., SNOMED Clinical Terms and MedDRA. The quality of the annotations is ensured by annotation guidelines, multi-stage annotations, measuring inter-annotator agreement, and final review of the annotations by a clinical terminologist. This corpus is useful for studies in the area of information extraction, or more generally text mining, from social media to detect possible adverse drug reactions from direct patient reports. The corpus is publicly available at https://data.csiro.au.1The data can be used for research purposes only, under the CSIRO data licence.1.},
author = {Karimi, Sarvnaz and Metke-Jimenez, Alejandro and Kemp, Madonna and Wang, Chen},
doi = {10.1016/j.jbi.2015.03.010},
isbn = {15320480 (Electronic)},
issn = {15320464},
journal = {Journal of Biomedical Informatics},
keywords = {Adverse drug reaction,Annotated corpus,Consumer reviews,Drug safety,Information extraction,MedDRA,Medical forum,SNOMED CT,Social media},
mendeley-groups = {DoMINO},
month = {jun},
pages = {73--81},
pmid = {25817970},
publisher = {Academic Press},
title = {{Cadec: A corpus of adverse drug event annotations}},
url = {https://www.sciencedirect.com/science/article/pii/S1532046415000532?via{\%}3Dihub},
volume = {55},
year = {2015}
}
@misc{Sarker2015,
abstract = {Objective: Automatic monitoring of Adverse Drug Reactions (ADRs), defined as adverse patient outcomes caused by medications, is a challenging research problem that is currently receiving significant attention from the medical informatics community. In recent years, user-posted data on social media, primarily due to its sheer volume, has become a useful resource for ADR monitoring. Research using social media data has progressed using various data sources and techniques, making it difficult to compare distinct systems and their performances. In this paper, we perform a methodical review to characterize the different approaches to ADR detection/extraction from social media, and their applicability to pharmacovigilance. In addition, we present a potential systematic pathway to ADR monitoring from social media. Methods: We identified studies describing approaches for ADR detection from social media from the Medline, Embase, Scopus and Web of Science databases, and the Google Scholar search engine. Studies that met our inclusion criteria were those that attempted to extract ADR information posted by users on any publicly available social media platform. We categorized the studies according to different characteristics such as primary ADR detection approach, size of corpus, data source(s), availability, and evaluation criteria. Results: Twenty-two studies met our inclusion criteria, with fifteen (68{\%}) published within the last two years. However, publicly available annotated data is still scarce, and we found only six studies that made the annotations used publicly available, making system performance comparisons difficult. In terms of algorithms, supervised classification techniques to detect posts containing ADR mentions, and lexicon-based approaches for extraction of ADR mentions from texts have been the most popular. Conclusion: Our review suggests that interest in the utilization of the vast amounts of available social media data for ADR monitoring is increasing. In terms of sources, both health-related and general social media data have been used for ADR detection-while health-related sources tend to contain higher proportions of relevant data, the volume of data from general social media websites is significantly higher. There is still very limited amount of annotated data publicly available , and, as indicated by the promising results obtained by recent supervised learning approaches, there is a strong need to make such data available to the research community.},
archivePrefix = {arXiv},
arxivId = {15334406},
author = {Sarker, Abeed and Ginn, Rachel and Nikfarjam, Azadeh and O'Connor, Karen and Smith, Karen and Jayaraman, Swetha and Upadhaya, Tejaswi and Gonzalez, Graciela},
booktitle = {Journal of Biomedical Informatics},
doi = {10.1016/j.jbi.2015.02.004},
eprint = {15334406},
isbn = {1532-0464},
issn = {15320464},
keywords = {Adverse drug reaction,Pharmacovigilance,Social media},
mendeley-groups = {DoMINO},
month = {apr},
pages = {202--212},
pmid = {25720841},
publisher = {Academic Press},
title = {{Utilizing social media data for pharmacovigilance: A review}},
url = {https://www.sciencedirect.com/science/article/pii/S1532046415000362?via{\%}3Dihub},
volume = {54},
year = {2015}
}
@article{Margraff2014,
abstract = {BACKGROUND: The modalities and contributions to drug safety of patient adverse drug reaction reporting systems in 50 countries have been reviewed and analysed.$\backslash$n$\backslash$nMETHODS: The means made available by National Health Competent Authorities (NCAs) for patients to report drug side effects were compared through literature review and questionnaire.$\backslash$n$\backslash$nRESULTS: Among the 50 countries included in this study, we found that direct patient reporting systems exist in 44 countries and represent 9 {\%} of total reports, the rest coming from healthcare professionals. Australia was the first, in 1964, and the United States has the system in which patients are the most involved. A total of 27 countries have a patient-specific reporting form, and 31 countries provide a form to complete online. In order to help patients, four countries constrain the description of the reaction and 12 constrain the choice of drug on the reporting form. Most of the surveyed countries request the patient's medical history (30 countries) and concomitant therapies (41 countries). The total number of fields per form ranges from 6 to 59, with a mean of 36 items.$\backslash$n$\backslash$nCONCLUSIONS: Most of the surveyed countries have implemented a patient adverse drug reaction reporting system. From this study, it seems that an online reporting form increases the rate of reporting. Currently, many different forms exist worldwide; these should be harmonized by considering the strengths and weaknesses of all existing forms. But above all, to increase the number of reports, each country should promote NCA-initiated adverse drug reactions reporting systems.},
author = {Margraff, Florence and Bertram, Delphine},
doi = {10.1007/s40264-014-0162-y},
isbn = {1179-1942 (Electronic) 0114-5916 (Linking)},
issn = {11791942},
journal = {Drug Safety},
mendeley-groups = {DoMINO},
month = {jun},
number = {6},
pages = {409--419},
pmid = {24748428},
publisher = {Springer International Publishing},
title = {{Adverse drug reaction reporting by patients: An overview of fifty countries}},
url = {http://link.springer.com/10.1007/s40264-014-0162-y},
volume = {37},
year = {2014}
}
@misc{Schmid,
abstract = {The TreeTagger is a tool for annotating text with part-of-speech and lemma information. It was developed by Helmut Schmid in the TC project at the Institute for Computational Linguistics of the University of Stuttgart. The TreeTagger has been successfully used to tag German, English, French, Italian, Danish, Dutch, Spanish, Bulgarian, Russian, Portuguese, Galician, Greek, Chinese, Swahili, Slovak, Slovenian, Latin, Estonian, Polish, Romanian, Czech, Coptic and old French texts and is adaptable to other languages if a lexicon and a manually tagged training corpus are available.},
author = {Schmid, Helmut},
mendeley-groups = {DoMINO},
title = {{TreeTagger, part of speech}},
url = {http://www.cis.uni-muenchen.de/{~}schmid/tools/TreeTagger/},
urldate = {2018-08-21}
}
@article{Stausberg2008,
abstract = {Objective: Reliability of diagnoses coding is essential for the use of routine data in a national health care system. The present investigation compares reliability of diagnoses coding with ICD-10 between three groups of coding subjects. Method: One hundred and eighteen students coded 15 diagnoses lists, 27 medical managers from hospitals 34 discharge letters, and 13 coding specialists 12 discharge letters. Agreement in principal diagnosis was assessed using Cohen's Kappa and the fraction of coincidences over the number of pairs, agreement for the full set of diagnoses with a previously developed measure pom. Results: Kappa values were fair (managers) or moderate (coders) for terminal codes with 0.27 and 0.42 (agreement 29.2{\%} versus 46.8{\%}), substantial for the chapter level with 0.71 and 0.72 (agreement 78.3{\%} versus 80.8{\%}). pomwas lower for the full set of diagnoses than for principal diagnoses, for example in case of managers with 0.21 versus 0.29 for terminal codes. Best results were achieved by students coding diagnoses lists. In summary, the results are remarkably lower than in earlier publications. Conclusion: The refinement of the ICD-10 accompanied by innumerous coding rules has established a complex environment that leads to significant uncertainties even for experts. Use of coded data for quality management, health care financing, and health care policy requires a remarkable simplification of ICD-10 to receive a valid image of health care reality. {\textcopyright} 2006 Elsevier Ireland Ltd. All rights reserved.},
author = {Stausberg, J{\"{u}}rgen and Lehmann, Nils and Kaczmarek, Dirk and Stein, Markus},
doi = {10.1016/j.ijmedinf.2006.11.005},
isbn = {1386-5056 (Print)},
issn = {13865056},
journal = {International Journal of Medical Informatics},
keywords = {Coding,Data quality,Diagnoses,Diagnosis related groups,ICD-10,Reliability},
mendeley-groups = {DoMINO},
month = {jan},
number = {1},
pages = {50--57},
pmid = {17185030},
publisher = {Elsevier},
title = {{Reliability of diagnoses coding with ICD-10}},
url = {https://www-sciencedirect-com.docelec.u-bordeaux.fr/science/article/pii/S1386505606002723},
volume = {77},
year = {2008}
}
@article{Breslin2010,
abstract = {The SIOC (Semantically-Interlinked Online Communities) Core Ontology provides the main concepts and properties required to describe information from online communities (e.g., message boards, wikis, weblogs, etc.) on the Semantic Web. This document contains a detailed description of the SIOC Core Ontology.},
author = {Br{\'{e}}slin, John},
journal = {WC Member},
mendeley-groups = {DoMINO},
number = {March 2010},
pages = {1--15},
title = {{SIOC Core Ontology Specification}},
url = {http://rdfs.org/sioc/spec/},
year = {2010}
}
@misc{Klein2018,
abstract = {About Stanford NER is a Java implementation of a Named Entity Recognizer. Named Entity Recognition (NER) labels sequences of words in a text which are the names of things, such as person and company names, or gene and protein names. It comes with well-engineered feature extractors for Named Entity Recognition, and many options for defining feature extractors. Included with the download are good named entity recognizers for English, particularly for the 3 classes (PERSON, ORGANIZATION, LOCATION), and we also make available on this page various other models for different languages and circumstances, including models trained on just the CoNLL 2003 English training data. Stanford NER is also known as CRFClassifier. The software provides a general implementation of (arbitrary order) linear chain Conditional Random Field (CRF) sequence models. That is, by training your own models on labeled data, you can actually use this code to build sequence models for NER or any other task. (CRF models were pioneered by Lafferty, McCallum, and Pereira (2001); see Sutton and McCallum (2006) or Sutton and McCallum (2010) for more comprehensible introductions.)},
author = {Klein, Dan and Manning, Christopher and Finkel, Jenny},
mendeley-groups = {DoMINO},
title = {{The Stanford Natural Language Processing Group}},
url = {https://nlp.stanford.edu/software/lex-parser.shtml https://nlp.stanford.edu/software/CRF-NER.html},
urldate = {2018-08-27},
year = {2018}
}
@article{Jouhet2018,
abstract = {In this paper, we describe the approach and results for our participation in the task 1 (multilingual information extraction) of the CLEF eHealth 2018 challenge. We addressed the task of automatically assigning ICD-10 codes to French death certificates. We used a dictionary-based approach using materials provided by the task organizers. The terms of the ICD-10 terminology were normalized, tokenized and stored in a tree data structure. The Levenshtein distance was used to detect ty-pos. Frequent abbreviations were detected by manually creating a small set of them. Our system achieved an F-score of 0.786 (precision: 0.794, recall: 0.779). These scores were substantially higher than the average score of the systems that participated in the challenge.},
archivePrefix = {arXiv},
arxivId = {arXiv:1807.03674v1},
author = {Cossin, S{\'{e}}bastien and Jouhet, Vianney and Mougin, Fleur and Diallo, Gayo and Thiessard, Frantz},
eprint = {arXiv:1807.03674v1},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Cossin et al. - 2018 - IAM at CLEF eHealth 2018 Concept Annotation and Coding in French Death Certificates.pdf:pdf},
keywords = {death certificates,entity recognition,guage processing,natural lan-,semantic annotation},
title = {{IAM at CLEF eHealth 2018: Concept Annotation and Coding in French Death Certificates}},
url = {https://arxiv.org/pdf/1807.03674.pdf},
year = {2018}
}
@misc{Bigeard2017,
abstract = {Discussion fora and social networks potentially provide various types of information, which usually are not available in other sources. For instance, it is possible to find in discussion fora information on habits and lifestyle of persons, while this information is seldom shared with medical doctors. Hence, it is possible to rely on this information for evaluating the real habits of patients. Yet, this information source is difficult to process, mainly because it offers some linguistic specificities. If the first step for exploring discussion fora consists of indexing the medical terms occurring in the messages with concepts from medical terminologies, this task is very difficult because patient utterances are different from official terminologies. We propose a method that permits to create and enrich lexica with terms and expressions meaning disorders or abnormalities, with a special interest to mood disorders. We exploit existing resources and non-supervised},
author = {Bigeard, Elise},
booktitle = {19es REncontres jeunes Chercheurs en Informatique pour le TAL (RECITAL 2017)},
doi = {10.1186/s13326-017-0153-x},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Jovanovi{\'{c}}, Bagheri - 2017 - Semantic annotation in biomedicine the current landscape.pdf:pdf},
isbn = {20411480 (Electronic)},
issn = {20411480},
keywords = {Discussion Forums,Natural Language Processing,disorders,extraction,patient language},
mendeley-groups = {DoMINO},
month = {dec},
number = {1},
pages = {15},
pmid = {28938912},
publisher = {BioMed Central},
title = {{Construction de lexiques pour l'extraction des mentions de maladies dans les forums de sant{\'{e}}}},
url = {http://jbiomedsem.biomedcentral.com/articles/10.1186/s13326-017-0153-x},
volume = {8},
year = {2017}
}
@misc{Systap,
author = {Systap},
mendeley-groups = {DoMINO},
title = {{Blazegraph - Wiki/About Blazegraph}},
url = {https://wiki.blazegraph.com/wiki/index.php/About{\_}Blazegraph},
urldate = {2018-08-30}
}
@article{Grouin2014,
abstract = {Background: To facilitate research applying Natural Language Processing to clinical documents, tools and resources are needed for the automatic de-identification of Electronic Health Records. Objective: This study investigates methods for developing a high-quality reference corpus for the de-identification of clinical documents in French. Methods: A corpus comprising a variety of clinical document types covering several medical specialties was pre-processed with two automatic de-identification systems from the MEDINA suite of tools: a rule-based system and a system using Conditional Random Fields (CRF). The pre-annotated documents were revised by two human annotators trained to mark ten categories of Protected Health Information (PHI). The human annotators worked independently and were blind to the system that produced the pre-annotations they were revising. The best pre-annotation system was applied to another random selection of 100 documents. After revision by one annotator, this set was used to train a statistical de-identification system. Results: Two gold standard sets of 100 documents were created based on the consensus of two human revisions of the automatic pre-annotations. The annotation experiment showed that (i) automatic pre-annotation obtained with the rule-based system performed better (F= 0.813) than the CRF system (F= 0.519), (ii) the human annotators spent more time revising the pre-annotations obtained with the rule-based system (from 102 to 160. minutes for 50 documents), compared to the CRF system (from 93 to 142. minutes for 50 documents), (iii) the quality of human annotation is higher when pre-annotations are obtained with the rule-based system (F-measure ranging from 0.970 to 0.987), compared to the CRF system (F-measure ranging from 0.914 to 0.981).Finally, only 20 documents from the training set were needed for the statistical system to outperform the pre-annotation systems that were trained on corpora from a medical speciality and hospital different from those in the reference corpus developed herein. Conclusion: We find that better pre-annotations increase the quality of the reference corpus but require more revision time. A statistical de-identification method outperforms our rule-based system when as little as 20 custom training documents are available. {\textcopyright} 2013 Elsevier Inc.},
author = {Grouin, Cyril and N{\'{e}}v{\'{e}}ol, Aur{\'{e}}lie},
doi = {10.1016/j.jbi.2013.12.014},
isbn = {{\%}(},
issn = {15320464},
journal = {Journal of Biomedical Informatics},
keywords = {Confidentiality,Electronic health records,France,Information dissemination,Natural language processing},
mendeley-groups = {DoMINO},
month = {aug},
pages = {151--161},
pmid = {24380818},
title = {{De-identification of clinical notes in French: Towards a protocol for reference corpus development}},
url = {https://www-sciencedirect-com.docelec.u-bordeaux.fr/science/article/pii/S1532046413002050 http://linkinghub.elsevier.com/retrieve/pii/S1532046413002050},
volume = {50},
year = {2014}
}
@techreport{Grouin2014a,
author = {Grouin, Cyril},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Grouin - 2014 - Medina-Manuel d'utilisation.pdf:pdf},
mendeley-groups = {DoMINO},
title = {{Medina-Manuel d'utilisation}},
url = {https://medina.limsi.fr/manuel-utilisation-medina.pdf},
year = {2014}
}
@article{Grouin2013,
author = {Grouin, Cyril},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Grouin - 2013 - Guide d'annotation Anonymisation de comptes rendus cliniques Cyril Grouin Guide d'annotation Anonymisation de comptes re.pdf:pdf},
keywords = {Anonymisation,Discharge reports},
mendeley-groups = {DoMINO},
title = {{Guide d'annotation - Anonymisation de comptes rendus cliniques}},
url = {https://perso.limsi.fr/grouin/publis/grouin{\_}guide-anonymisation.pdf},
year = {2013}
}
@inproceedings{Manning2014,
abstract = {We describe the design and use of the Stanford CoreNLP toolkit, an extensible pipeline that provides core natural language analysis. This toolkit is quite widely used, both in the research NLP community and also among commercial and government users of open source NLP technology. We suggest that this follows from a simple, approachable design, straightforward interfaces, the inclusion of robust and good quality analysis components, and not requiring use of a large amount of associated baggage.},
archivePrefix = {arXiv},
arxivId = {arXiv:1011.1669v3},
author = {Manning, Christopher and Surdeanu, Mihai and Bauer, John and Finkel, Jenny and Bethard, Steven and McClosky, David},
booktitle = {Proceedings of 52nd Annual Meeting of the Association for Computational Linguistics: System Demonstrations},
doi = {10.3115/v1/P14-5010},
eprint = {arXiv:1011.1669v3},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Manning et al. - Unknown - The Stanford CoreNLP Natural Language Processing Toolkit.pdf:pdf},
isbn = {9781941643006},
issn = {1098-6596},
mendeley-groups = {DoMINO},
pages = {55--60},
pmid = {25246403},
title = {{The Stanford CoreNLP Natural Language Processing Toolkit}},
url = {https://nlp.stanford.edu/pubs/StanfordCoreNlp2014.pdf http://aclweb.org/anthology/P14-5010},
year = {2014}
}
@article{Bigeard2018,
abstract = {Misuses may happen when patients do not follow the prescriptions and do actions which lead to potentially harmful situations, such as intakes of incorrect dosage (overuse or underuse) or drug use for indications different from those prescribed. Although such situations are dangerous, patients usually do not report the misuse of drugs to their physicians. Hence, other sources of information are necessary for studying these issues. We assume that online health fora can provide such information and propose to exploit them. The general purpose of our work is the automatic detection and classification of drug misuses. To achieve this purpose, we propose a several-step method, which main steps are: (1) indexing of messages with extended vocabulary adapted to social media writing; (2) creation of typology of drug misuses; and (3) automatic classification of messages according to whether they contain drug misuses or not. We present the results obtained at different steps and discuss them. As for the general objectives, the current methods permit to detect the misuses with up to 0.773 F-measure.},
author = {Bigeard, Elise and Grabar, Natalia and Thiessard, Frantz},
doi = {10.3389/fphar.2018.00791},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Bigeard, Grabar, Thiessard - 2018 - Detection and Analysis of Drug Misuses. A Study Based on Social Media Messages.pdf:pdf},
issn = {1663-9812},
journal = {Frontiers in Pharmacology},
keywords = {France,Natural Language Processing,Patient Safety,Social Media,drug misuse},
mendeley-groups = {DoMINO},
month = {jul},
pages = {791},
publisher = {Frontiers},
title = {{Detection and Analysis of Drug Misuses. A Study Based on Social Media Messages}},
url = {https://www.frontiersin.org/article/10.3389/fphar.2018.00791/full},
volume = {9},
year = {2018}
}
@article{WorldHealthOrganizationWHO2015,
abstract = {This report provides a concise summary of the consequences of poor adherence for health and economics. It also discusses the options available for improving adherence, and demonstrates the potential impact on desired health outcomes and health care budgets. It is hoped that this report will lead to new thinking on policy development and action on adherence to long-term therapies. Ch. I. Defining adherence -- Ch. II. The magnitude of the problem of poor adherence -- Ch. III. How does poor adherence affect policy makers and health managers? -- Ch. IV. Lessons learned -- Ch. V. Towards the solution -- Ch. VI. How can improved adherence be translated into health and economics benefits? -- Ch. VII. Asthma -- Ch. VIII. Cancer (palliative care) -- Ch. IX. Depression -- Ch. X. Diabetes -- Ch. XI. Epilepsy -- Ch. XII. HIV/AIDS -- Ch. XIII. Hypertension -- Ch. XIV. Tobacco smoking cessation -- Ch. XV. Tuberculosis -- Annex I. Behavioural mechanisms explaining adherence -- Annex II. Statements by stakeholders -- Annex III. Table of reported factors by condition and dimension -- Annex IV. Table of reported interventions by condition and dimension -- Annex V. Global adherence interdisciplinary network (GAIN).},
author = {{World Health Organization(WHO)}},
isbn = {92 4 154599 2},
journal = {WHO},
keywords = {Publication [doctype],aids,depression [subject],depressive symptoms,diabetes [subject],diabetes mellitus,drug,drug therapy,drugs,glucose intolerance,hiv,hiv infections,hiv/aids [subject],hyperglycaemia,medicines,medicines [subject],pharmaceutical preparations,pharmaceutical products,pharmaceuticals,pharmacology,psychotropic drugs},
mendeley-groups = {DoMINO/Bigeard},
pages = {Cap XIII 107--114},
publisher = {World Health Organization},
title = {{WHO | ADHERENCE TO LONG-TERM THERAPIES: EVIDENCE FOR ACTION}},
url = {http://www.who.int/chp/knowledge/publications/adherence{\_}report/en/},
year = {2015}
}
@incollection{Haynes2002,
abstract = {BACKGROUND: People who are prescribed self-administered medications typically take less than half the prescribed doses. Efforts to assist patients with adherence to medications might improve the benefits and efficiency of health care, but also might increase its adverse effects. OBJECTIVES: To update a review summarising the results of randomised controlled trials (RCTs) of interventions to help patients follow prescriptions for medications for medical problems, focusing on trials that measured both adherence and clinical outcomes. SEARCH STRATEGY: Computerised searches to August 2001 in MEDLINE, CINAHL, The Cochrane Library, International Pharmaceutical Abstracts (IPA) PsychInfo, and Sociofile; bibliographies in articles on patient adherence; articles in the reviewers' personal collections; and contact with authors of original and review articles on the topic. SELECTION CRITERIA: Articles were selected if they reported an unconfounded RCT of an intervention to improve adherence with prescribed medications, measuring both medication adherence and treatment outcome, with at least 80{\%} follow-up of each group studied and, for long-term treatments, at least six months follow-up for studies with positive initial findings. DATA COLLECTION AND ANALYSIS: Information on study design features, interventions and controls, and results were extracted by one reviewer and confirmed by at least one other reviewer. The studies were too disparate to warrant meta-analysis. MAIN RESULTS: For short-term treatments, one of three interventions reported in three RCTs showed an effect on both adherence and clinical outcome. Eighteen of 36 interventions for long-term treatments reported in 30 RCTs were associated with improvements in adherence, but only 16 interventions led to improvements in treatment outcomes. Almost all of the interventions that were effective for long-term care were complex, including combinations of more convenient care, information, reminders, self-monitoring, reinforcement, counselling, family therapy, and other forms of additional supervision or attention by a health care provider (physician, nurse, pharmacist or other). Even the most effective interventions did not lead to large improvements in adherence and treatment outcomes. Two studies showed that telling patients about adverse effects of treatment did not affect their adherence. REVIEWER'S CONCLUSIONS: The full benefits of medications cannot be realised at currently achievable levels of adherence. Current methods of improving adherence for chronic health problems are mostly complex and not very effective. Innovations to assist patients to follow medication prescriptions are needed.},
address = {Chichester, UK},
author = {Haynes, RB and McDonald, H and Garg, AX and Montague, P},
booktitle = {Cochrane Database of Systematic Reviews},
doi = {10.1002/14651858.CD000011},
file = {::},
isbn = {1469-493X (Electronic)$\backslash$r1361-6137 (Linking)},
issn = {1469-493X},
keywords = {*Drug Therapy,*Medication Adherence,Patient Education as Topic,Publication Bias,Randomized Controlled Trials as Topic,Self Administration},
mendeley-groups = {DoMINO},
month = {apr},
number = {2},
pmid = {12076376},
publisher = {John Wiley {\&} Sons, Ltd},
title = {{Interventions for helping patients to follow prescriptions for medications}},
url = {http://doi.wiley.com/10.1002/14651858.CD000011},
year = {2002}
}
@article{Xie2017,
author = {Xie, Jiaheng and Zeng, Daniel Dajun and Marcum, Zachary A.},
doi = {10.1177/2042098617729318},
issn = {20420994},
journal = {Therapeutic Advances in Drug Safety},
mendeley-groups = {DoMINO},
month = {dec},
number = {12},
pages = {375--377},
publisher = {SAGE PublicationsSage UK: London, England},
title = {{Using deep learning to improve medication safety: the untapped potential of social media}},
url = {http://journals.sagepub.com/doi/10.1177/2042098617729318},
volume = {8},
year = {2017}
}
@article{Kalyanam2017,
abstract = {Introduction Nonmedical use of prescription medications/drugs (NMUPD) is a serious public health threat, particularly in relation to the prescription opioid analgesics abuse epidemic. While attention to this problem has been growing, there remains an urgent need to develop novel strategies in the field of “digital epidemiology” to better identify, analyze and understand trends in NMUPD behavior. Methods We conducted surveillance of the popular microblogging site Twitter by collecting 11 million tweets filtered for three commonly abused prescription opioid analgesic drugs Percocet{\"{i}}¿½ (acetaminophen/oxycodone), OxyContin{\"{i}}¿½ (oxycodone), and Oxycodone. Unsupervised machine learning was applied on the subset of tweets for each analgesic drug to discover underlying latent themes regarding risk behavior. A two-step process of obtaining themes, and filtering out unwanted tweets was carried out in three subsequent rounds of machine learning. Results Using this methodology, 2.3M tweets were identified that contained content relevant to analgesic NMUPD. The underlying themes were identified for each drug and the most representative tweets of each theme were annotated for NMUPD behavioral risk factors. The primary themes identified evidence high levels of social media discussion about polydrug abuse on Twitter. This included specific mention of various polydrug combinations including use of other classes of prescription drugs, and illicit drug abuse. Conclusions This study presents a methodology to filter Twitter content for NMUPD behavior, while also identifying underlying themes with minimal human intervention. Results from the study track accurately with the inclusion/exclusion criteria used to isolate NMUPD-related risk behaviors of interest and also provides insight on NMUPD behavior that has a high level of social media engagement. Results suggest that this could be a viable methodology for use in big data substance abuse surveillance, data collection, and analysis in comparison to other studies that rely upon content analysis and human coding schemes.},
author = {Kalyanam, Janani and Katsuki, Takeo and {R.G. Lanckriet}, Gert and Mackey, Tim K.},
doi = {10.1016/j.addbeh.2016.08.019},
isbn = {0306-4603(Print)},
issn = {18736327},
journal = {Addictive Behaviors},
keywords = {Digital surveillance,Nonmedical use of prescription drugs,Prescription opioid abuse,Social media,Substance abuse,Twitter},
mendeley-groups = {DoMINO},
month = {feb},
pages = {289--295},
pmid = {27568339},
title = {{Exploring trends of nonmedical use of prescription drugs and polydrug abuse in the Twittersphere using unsupervised machine learning}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/27568339 http://linkinghub.elsevier.com/retrieve/pii/S0306460316302994},
volume = {65},
year = {2017}
}
@article{Cameron2013,
abstract = {Objectives: The role of social media in biomedical knowledge mining, including clinical, medical and healthcare informatics, prescription drug abuse epidemiology and drug pharmacology, has become increasingly significant in recent years. Social media offers opportunities for people to share opinions and experiences freely in online communities, which may contribute information beyond the knowledge of domain professionals. This paper describes the development of a novel semantic web platform called PREDOSE ( PREscription Drug abuse Online Surveillance and Epidemiology), which is designed to facilitate the epidemiologic study of prescription (and related) drug abuse practices using social media. PREDOSE uses web forum posts and domain knowledge, modeled in a manually created Drug Abuse Ontology (DAO - pronounced dow), to facilitate the extraction of semantic information from User Generated Content (UGC), through combination of lexical, pattern-based and semantics-based techniques. In a previous study, PREDOSE was used to obtain the datasets from which new knowledge in drug abuse research was derived. Here, we report on various platform enhancements, including an updated DAO, new components for relationship and triple extraction, and tools for content analysis, trend detection and emerging patterns exploration, which enhance the capabilities of the PREDOSE platform. Given these enhancements, PREDOSE is now more equipped to impact drug abuse research by alleviating traditional labor-intensive content analysis tasks. Methods: Using custom web crawlers that scrape UGC from publicly available web forums, PREDOSE first automates the collection of web-based social media content for subsequent semantic annotation. The annotation scheme is modeled in the DAO, and includes domain specific knowledge such as prescription (and related) drugs, methods of preparation, side effects, and routes of administration. The DAO is also used to help recognize three types of data, namely: (1) entities, (2) relationships and (3) triples. PREDOSE then uses a combination of lexical and semantic-based techniques to extract entities and relationships from the scraped content, and a top-down approach for triple extraction that uses patterns expressed in the DAO. In addition, PREDOSE uses publicly available lexicons to identify initial sentiment expressions in text, and then a probabilistic optimization algorithm (from related research) to extract the final sentiment expressions. Together, these techniques enable the capture of fine-grained semantic information, which facilitate search, trend analysis and overall content analysis using social media on prescription drug abuse. Moreover, extracted data are also made available to domain experts for the creation of training and test sets for use in evaluation and refinements in information extraction techniques. Results: A recent evaluation of the information extraction techniques applied in the PREDOSE platform indicates 85{\%} precision and 72{\%} recall in entity identification, on a manually created gold standard dataset. In another study, PREDOSE achieved 36{\%} precision in relationship identification and 33{\%} precision in triple extraction, through manual evaluation by domain experts. Given the complexity of the relationship and triple extraction tasks and the abstruse nature of social media texts, we interpret these as favorable initial results. Extracted semantic information is currently in use in an online discovery support system, by prescription drug abuse researchers at the Center for Interventions, Treatment and Addictions Research (CITAR) at Wright State University. Conclusion: A comprehensive platform for entity, relationship, triple and sentiment extraction from such abstruse texts has never been developed for drug abuse research. PREDOSE has already demonstrated the importance of mining social media by providing data from which new findings in drug abuse research were uncovered. Given the recent platform enhancements, including the refined DAO, components for relationship and triple extraction, and tools for content, trend and emerging pattern analysis, it is expected that PREDOSE will play a significant role in advancing drug abuse epidemiology in future. {\textcopyright} 2013 Elsevier Inc.},
archivePrefix = {arXiv},
arxivId = {NIHMS150003},
author = {Cameron, Delroy and Smith, Gary A and Daniulaityte, Raminta and Sheth, Amit P and Dave, Drashti and Chen, Lu and Anand, Gaurish and Carlson, Robert and Watkins, Kera Z and Falck, Russel},
doi = {10.1016/j.jbi.2013.07.007},
eprint = {NIHMS150003},
file = {::},
isbn = {1532-0464},
issn = {15320464},
journal = {Journal of Biomedical Informatics},
keywords = {Drug Abuse Ontology,Entity identification,Opiod abuse,Prescription drug abuse,Relationship extraction,Semantic web,Sentiment extraction,Social media,Triple extraction},
mendeley-groups = {DoMINO},
number = {6},
pages = {985--997},
pmid = {23892295},
title = {{PREDOSE: A semantic web platform for drug abuse epidemiology using social media}},
url = {http://dx.doi.org/10.1016/j.jbi.2013.07.007},
volume = {46},
year = {2013}
}
@misc{Charles-Smith2015,
abstract = {OBJECTIVE: Research studies show that social media may be valuable tools in the disease surveillance toolkit used for improving public health professionals' ability to detect disease outbreaks faster than traditional methods and to enhance outbreak response. A social media work group, consisting of surveillance practitioners, academic researchers, and other subject matter experts convened by the International Society for Disease Surveillance, conducted a systematic primary literature review using the PRISMA framework to identify research, published through February 2013, answering either of the following questions: Can social media be integrated into disease surveillance practice and outbreak management to support and improve public health?Can social media be used to effectively target populations, specifically vulnerable populations, to test an intervention and interact with a community to improve health outcomes?Examples of social media included are Facebook, MySpace, microblogs (e.g., Twitter), blogs, and discussion forums. For Question 1, 33 manuscripts were identified, starting in 2009 with topics on Influenza-like Illnesses (n = 15), Infectious Diseases (n = 6), Non-infectious Diseases (n = 4), Medication and Vaccines (n = 3), and Other (n = 5). For Question 2, 32 manuscripts were identified, the first in 2000 with topics on Health Risk Behaviors (n = 10), Infectious Diseases (n = 3), Non-infectious Diseases (n = 9), and Other (n = 10).$\backslash$n$\backslash$nCONCLUSIONS: The literature on the use of social media to support public health practice has identified many gaps and biases in current knowledge. Despite the potential for success identified in exploratory studies, there are limited studies on interventions and little use of social media in practice. However, information gleaned from the articles demonstrates the effectiveness of social media in supporting and improving public health and in identifying target populations for intervention. A primary recommendation resulting from the review is to identify opportunities that enable public health professionals to integrate social media analytics into disease surveillance and outbreak management practice.},
archivePrefix = {arXiv},
arxivId = {1401.1032},
author = {Charles-Smith, Lauren E. and Reynolds, Tera L. and Cameron, Mark A. and Conway, Mike and Lau, Eric H.Y. and Olsen, Jennifer M. and Pavlin, Julie A. and Shigematsu, Mika and Streichert, Laura C. and Suda, Katie J. and Corley, Courtney D.},
booktitle = {PLoS ONE},
doi = {10.1371/journal.pone.0139701},
editor = {Braunstein, Lidia Adriana},
eprint = {1401.1032},
file = {::},
isbn = {1932-6203},
issn = {19326203},
mendeley-groups = {DoMINO},
month = {oct},
number = {10},
pages = {e0139701},
pmid = {26437454},
publisher = {Public Library of Science},
title = {{Using social media for actionable disease surveillance and outbreak management: A systematic literature review}},
url = {http://dx.plos.org/10.1371/journal.pone.0139701},
volume = {10},
year = {2015}
}
@article{Iniacio2017,
abstract = {Keywords adverse drug reaction reporting systems, drug monitoring, drug-related side effects and adverse reactions, patients, pharmacovigilance AIMS Current trends in pharmacovigilance systems are veering towards patient involvement in spontaneous reporting of adverse drug reactions (ADRs). The aim of the current systematic review was to identify what is known and what remains unknown with respect to patient reporting to pharmacovigilance systems. METHODS A systematic literature search was conducted in PubMed, CINAHL, Journals@Ovid and the Cochrane Library. Studies were included if they contained: (i) reviews about patient reporting; (ii) evaluation of patient reports to national or supranational pharmacovigilance authorities; (iii) a comparison between patient and healthcare professional (HCP) reports submitted to pharmacovigilance authorities; and (iv) surveys of patient experiences, opinions and awareness about reporting ADRs. The methodological quality of the studies was assessed according to principles of Grading of Recommendations, Assessment, Development and Evaluations (GRADE). RESULTS A total of thirty four studies were included. Five of the studies were reviews (two of which systematic reviews), fourteen retrospective observational studies, nine surveys and six applied mixed research methods. Patient reporting has the advantages of bringing novel information about ADRs. It provides a more detailed description of ADRs, and reports about different drugs and system organ classes when compared with HCP reporting. In addition, patients describe the severity and impact of ADRs on daily life, complementing information derived from HCPs. Patient reporting is relatively rare in most countries. CONCLUSIONS Patient reporting adds new information, and perspective about ADRs in a way otherwise unavailable. This can contribute to better decision-making processes in regulatory activities. The present review identified gaps in knowledge that should be addressed to improve our understanding of the full potential and drawbacks of patient reporting. • The reporting of suspected adverse drug reactions (ADRs) in clinical practice is the backbone of postmarket surveillance for early detection of new, rare and serious ADRs. • The potential of patient reporting has been described in the literature as a noteworthy source of new information about drug safety, particularly the safety profiles of individual medicines. • A growing number of countries are involving patient{\ldots}},
author = {In{\"{i}}acio, Pedro and Cavaco, Afonso and Airaksinen, Marja},
doi = {10.1111/bcp.13098},
file = {::},
isbn = {1365-2125 (Electronic) 0306-5251 (Linking)},
issn = {13652125},
journal = {British Journal of Clinical Pharmacology},
keywords = {adverse drug reaction reporting systems,drug monitoring,drug-related side effects and adverse reactions,patients,pharmacovigilance},
mendeley-groups = {DoMINO},
number = {2},
pages = {227--246},
pmid = {27558545},
title = {{The value of patient reporting to the pharmacovigilance system: a systematic review}},
url = {http://www.ff.ul.pt/ufs/files/2015/09/CuriosidadeCientifica{\_}Novembro2016.pdf},
volume = {83},
year = {2017}
}
@techreport{Cossin2018,
abstract = {De nombreuses sources de donn{\'{e}}es non structur{\'{e}}es comme les dossiers patients informatis{\'{e}}s, les articles scientifiques, les recommandations de bonnes pratiques et les forums mentionnent les m{\'{e}}dicaments. La d{\'{e}}tection des m{\'{e}}dicaments en texte libre est une {\'{e}}tape importante pour faciliter leur recherche et extraire des informations sur ces derniers. Dans cet article, nous d{\'{e}}crivons la construction de ROMEDI (r{\'{e}}f{\'{e}}rentiel ouvert du m{\'{e}}dicament), une terminologie cr{\'{e}}{\'{e}}e pour d{\'{e}}tecter les m{\'{e}}dicaments dans des donn{\'{e}}es en texte libre. Un programme bas{\'{e}} sur cette terminologie obtient une F-mesure {\`{a}} 0,97 pour d{\'{e}}tecter les m{\'{e}}dicaments au sein d'un formulaire utilis{\'{e}} par des urgentistes.},
author = {Cossin, S{\'{e}}bastien and Loustau, Romain and Jouhet, Vianney and L{\'{e}}tinier, Louis and Mougin, Fleur and Evrard, Gr{\'{e}}goire and Gil-Jardin{\'{e}}, C{\'{e}}dric and Diallo, Gayo and Thiessard, Frantz},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Cossin et al. - 2018 - ROMEDI, une terminologie m{\'{e}}dicale fran{\c{c}}aise pour la d{\'{e}}tection des m{\'{e}}dicaments en texte libre.pdf:pdf},
keywords = {IA sant{\'{e}}},
mendeley-groups = {DoMINO},
mendeley-tags = {IA sant{\'{e}}},
pages = {17/106},
title = {{ROMEDI, une terminologie m{\'{e}}dicale fran{\c{c}}aise pour la d{\'{e}}tection des m{\'{e}}dicaments en texte libre}},
url = {https://pfia2018.loria.fr/wp-content/uploads/2018/07/CommunicationsIASant{\'{e}}{\_}3juillet2018.pdf},
year = {2018}
}
@misc{WHO,
abstract = {In the ATC classification system, the active substances are classified in a hierarchy with five different levels. The system has fourteen main anatomical/pharmacological groups or 1st levels. Each ATC main group is divided into 2nd levels which could be either pharmacological or therapeutic groups. The 3rd and 4th levels are chemical, pharmacological or therapeutic subgroups and the 5th level is the chemical substance. The 2nd, 3rd and 4th levels are often used to identify pharmacological subgroups when that is considered more appropriate than therapeutic or chemical subgroups. The complete classification of metformin illustrates the structure of the code: A Alimentary tract and metabolism (1st level, anatomical main group) A10 Drugs used in diabetes (2nd level, therapeutic subgroup) A10B Blood glucose lowering drugs, excl. insulins (3rd level, pharmacological subgroup) A10BA Biguanides (4th level, chemical subgroup) A10BA02 metformin (5th level, chemical substance) Thus, in the ATC system all plain metformin preparations are given the code A10BA02.},
author = {{World Health Organization(WHO)}},
mendeley-groups = {DoMINO},
title = {{WHOCC - ATC Structure and principles}},
url = {https://www.whocc.no/atc/structure{\_}and{\_}principles/},
urldate = {2018-09-05}
}
@phdthesis{Marton2016,
abstract = {Introduction : Les repr{\'{e}}sentations du prescripteur sur le m{\'{e}}susage (comme celles du patient) influencent la relation th{\'{e}}rapeutique et peuvent, dans certains cas, diminuer les chances de gu{\'{e}}rison du patient d{\'{e}}pendant aux opiac{\'{e}}s. Objectifs : Clarifier les caract{\'{e}}ristiques du m{\'{e}}susage intraveineux de la bupr{\'{e}}norphine afin de rationaliser et am{\'{e}}liorer la prise en charge m{\'{e}}dicale des patients d{\'{e}}pendants aux opiac{\'{e}}s. Mat{\'{e}}riel et M{\'{e}}thodes : Le travail consiste en une {\'{e}}tude syst{\'{e}}matis{\'{e}}e des donn{\'{e}}es de synth{\`{e}}se fran{\c{c}}aise, reflet du corpus de connaissances valid{\'{e}} pour les m{\'{e}}decins sp{\'{e}}cialis{\'{e}}s en addictologie et futurs praticiens. Dans un second temps, mise en perspective des r{\'{e}}sultats avec les donn{\'{e}}es scientifiques actuellement disponibles. R{\'{e}}sultats Les donn{\'{e}}es fran{\c{c}}aises locales stigmatisent le « mauvais » comportement, {\`{a}} vis{\'{e}}e r{\'{e}}cr{\'{e}}ative et {\'{e}}troitement li{\'{e}}e {\`{a}} la substance (Bupr{\'{e}}norphine) du patient. L'objectif th{\'{e}}rapeutique du m{\'{e}}decin prescripteur est la suppression des sympt{\^{o}}mes du syndr{\^{o}}me de sevrage. A l'oppos{\'{e}}, les donn{\'{e}}es de la litt{\'{e}}rature scientifique sp{\'{e}}cialis{\'{e}}e r{\'{e}}centes d{\'{e}}crivent le m{\'{e}}susage comme un comportement « universel », conditionn{\'{e}}, n'induisant pas une mortalit{\'{e}} {\'{e}}lev{\'{e}}, et tr{\`{e}}s majoritairement (75{\%} des cas) r{\'{e}}alis{\'{e}} dans une attention th{\'{e}}rapeutique conforme {\`{a}} son indication : la suppression des sympt{\^{o}}mes de sevrage. Le m{\'{e}}susage est donc favoris{\'{e}} par le sous dosage th{\'{e}}rapeutique pratiqu{\'{e}} par le m{\'{e}}decin. L'objectif th{\'{e}}rapeutique pr{\'{e}}conis{\'{e}} est donc la suppression du craving, necessitant la prescription (supervis{\'{e}}e) de haut dosage de bupr{\'{e}}norphine (allant jusqu'{\`{a}} 32mg/j, hors AMM). Conclusion : La qualit{\'{e}} de la prescription (d{\'{e}}livrance supervis{\'{e}}e , dose bupr{\'{e}}norphine adapt{\'{e}}e {\`{a}} l'{\'{e}}limination du craving), et la relation de confiance m{\'{e}}decin malade, sont les cl{\'{e}}s pour une prise en charge optimale d'un patient d{\'{e}}pendant aux opiac{\'{e}}s.},
author = {Marton, Delly},
keywords = {M{\'{e}}susage,autom{\'{e}}dication,d{\'{e}}tournement},
mendeley-tags = {M{\'{e}}susage,d{\'{e}}tournement,autom{\'{e}}dication},
school = {Bordeaux},
title = {{M{\'{e}}susage : d{\'{e}}finition, inventaire et analyse des donn{\'{e}}es disponibles. Sp{\'{e}}cificit{\'{e}} de la bupr{\'{e}}norphine et mise en perspective avec les autres m{\'{e}}dicaments}},
url = {https://dumas.ccsd.cnrs.fr/dumas-01301621},
year = {2016}
}
@techreport{Henriet2016,
abstract = {Contexte : La prescription diff{\'{e}}r{\'{e}}e d'antibiotiques (PDA) consiste {\`{a}} remettre au patient une ordonnance avec la consigne de d{\'{e}}buter l'antibioth{\'{e}}rapie apr{\`{e}}s un d{\'{e}}lai donn{\'{e}} en fonction de l'{\'{e}}volution des sympt{\^{o}}mes. Ce type de prescription existe en m{\'{e}}decine g{\'{e}}n{\'{e}}rale ; il est peu {\'{e}}tudi{\'{e}} en France. Objectif : L'objectif principal de l'{\'{e}}tude {\'{e}}tait de quantifier le m{\'{e}}susage de la PDA dans les infections des voies respiratoires. Le m{\'{e}}susage {\'{e}}tait d{\'{e}}fini par une consommation de l'antibiotique avant le d{\'{e}}lai prescrit et / ou pendant une dur{\'{e}}e diff{\'{e}}rente de celle prescrite. L'objectif secondaire {\'{e}}tait d'appr{\'{e}}cier l'existence de variables pouvant l'influencer. M{\'{e}}thode : Une {\'{e}}tude quantitative observationnelle descriptive et transversale a {\'{e}}t{\'{e}} r{\'{e}}alis{\'{e}}e entre janvier et avril 2016. Etait inclus, tout patient, sans crit{\`{e}}re d'{\^{a}}ge ni de comorbidit{\'{e}}, consultant aupr{\`{e}}s d'un sp{\'{e}}cialiste en m{\'{e}}decine g{\'{e}}n{\'{e}}rale dans le cadre d'une infection respiratoire haute ou basse pour laquelle il b{\'{e}}n{\'{e}}ficiait d'une PDA. Le recueil des donn{\'{e}}es {\'{e}}tait effectu{\'{e}} par questionnaire t{\'{e}}l{\'{e}}phonique aupr{\`{e}}s du patient dans un d{\'{e}}lai de 3 semaines apr{\`{e}}s la consultation. R{\'{e}}sultats : 88 patients dont 6 perdus de vue ont {\'{e}}t{\'{e}} inclus par 29 m{\'{e}}decins. Parmi les 82 questionnaires exploitables, 15 m{\'{e}}susages ont {\'{e}}t{\'{e}} retrouv{\'{e}}s soit 18,3{\%} (IC 95{\%} [9,9{\%} - 26,7 {\%}]) : 10 par consommation de l'antibiotique avant le d{\'{e}}lai, 5 par non-respect de la dur{\'{e}}e. Une diff{\'{e}}rence statistiquement significative a {\'{e}}t{\'{e}} retrouv{\'{e}}e chez les patients qui s'attendaient {\`{a}} recevoir une prescription d'antibiotique au moment de la consultation. Conclusion : Ce r{\'{e}}sultat tend {\`{a}} montrer une observance satisfaisante des consignes du m{\'{e}}decin. La PDA n'est probablement pas une solution optimale mais peut pr{\'{e}}senter des avantages. Les patients qui s'attendent {\`{a}} avoir un antibiotique paraissent plus {\`{a}} risque de faire un m{\'{e}}susage. Une {\'{e}}tude quantitative d'envergure pourrait {\^{e}}tre int{\'{e}}ressante pour connaitre pr{\'{e}}cis{\'{e}}ment la pr{\'{e}}valence de cette pratique},
address = {Grenoble},
author = {Henriet, No{\'{e}}mie and Reynier, William},
file = {::},
keywords = {Antibiotiques,M{\'{e}}decine G{\'{e}}n,Prescription diff{\'{e}}r{\'{e}}e},
mendeley-groups = {DoMINO},
mendeley-tags = {Antibiotiques,Prescription diff{\'{e}}r{\'{e}}e,M{\'{e}}decine G{\'{e}}n},
title = {{{\'{E}}tude quantitative du m{\'{e}}susage de la prescription diff{\'{e}}r{\'{e}}e d'antibiotiques dans les infections respiratoires en M{\'{e}}decine G{\'{e}}n{\'{e}}rale}},
url = {http://www.cfcopies.com/juridique/droit-auteur},
year = {2016}
}
@article{Chen2018,
abstract = {Background: The Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) have recognized social media as a new data source to strengthen their activities regarding drug safety. Objective: Our objective in the ADR-PRISM project was to provide text mining and visualization tools to explore a corpus of posts extracted from social media. We evaluated this approach on a corpus of 21 million posts from five patient forums, and conducted a qualitative analysis of the data available on methylphenidate in this corpus. Methods: We applied text mining methods based on named entity recognition and relation extraction in the corpus, followed by signal detection using proportional reporting ratio (PRR). We also used topic modelling based on the Correlated Topic Model to obtain the list of thematics in the corpus and classify the messages based on their topics. Results: We automatically identified 3443 posts about methylphenidate published between 2007 and 2016, among which 61 adverse drug reactions (ADR) were automatically detected. Two pharmacovigilance experts evaluated manually the quality of automatic identification, and a f-measure of 0.57 was reached. Patient's reports were mainly neuro-psychiatric effects. Applying PRR, 67{\%} of the ADRs were signals, including most of the neuro-psychiatric symptoms but also palpitations. Topic modelling showed that the most represented topics were related to Childhood and Treatment initiation, but also Side effects. Cases of misuse were also identified in this corpus, including recreational use and abuse. Conclusion: Named entity recognition combined with signal detection and topic modelling have demonstrated their complementarity in mining social media data. An in-depth analysis focused on methylphenidate showed that this approach was able to detect potential signals and to provide better understanding of patients' behaviors regarding drugs, including misuse.},
author = {Chen, Xiaoyi and Faviez, Carole and Schuck, St{\'{e}}phane and Lillo-Le-Lou{\"{e}}t, Agn{\`{e}}s and Texier, Nathalie and Dahamna, Badisse and Huot, Charles and Foulqui{\'{e}}, Pierre and Pereira, Suzanne and Leroux, Vincent and Karapetiantz, Pierre and Guenegou-Arnoux, Armelle and Katsahian, Sandrine and Bousquet, C{\'{e}}dric and Burgun, Anita},
doi = {10.3389/fphar.2018.00541},
issn = {16639812},
journal = {Frontiers in Pharmacology},
keywords = {Data mining,Drug misuse,Drug-related side effects and adverse reactions,Methylphenidate,Natural language processing,Pharmacovigilance,Social media},
number = {MAY},
pages = {541},
pmid = {29881351},
publisher = {Frontiers Media SA},
title = {{Mining patients' narratives in social media for pharmacovigilance: Adverse effects and misuse of methylphenidate}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/29881351 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5978246},
volume = {9},
year = {2018}
}
@article{Kathait2017,
abstract = {The growing abundance of text articles in internet requires automated tagging using key phrases. The automated key phrase generation of resources helps in the information retrieval. To generate the key phrases for texts from all possible domains, the need is an automated approach that would extract the key ideas directly from the text itself. In this paper, we have suggested a methodology that uses the noun words and phrases, their occurrence and co-occurrences to generate the keywords. The method, employing both the statistical and linguistic features, has been successful in extracting the keywords and phrases to tag a text that best summarizes its content.},
author = {Kathait, Shailendra Singh and Tiwari, Shubhrita and Varshney, Anubha and Sharma, Ajit},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Kathait et al. - 2017 - Unsupervised Key-phrase Extraction using Noun Phrases.pdf:pdf},
journal = {International Journal of Computer Applications},
keywords = {a text and how,but the greatest challenge,can be associated with,characterizes a key-phrase,generated from a text,in this,interpretable rules as to,they can be,what,while this can produce},
mendeley-groups = {DoMINO},
number = {1},
pages = {1--5},
title = {{Unsupervised Key-phrase Extraction using Noun Phrases}},
url = {https://pdfs.semanticscholar.org/cd96/3a530f1178833dc14f1d23545aaaacbf693e.pdf},
volume = {162},
year = {2017}
}
@article{Banon,
author = {Banon, Shay},
mendeley-groups = {DoMINO},
title = {{Elasticsearch}},
url = {https://www.elastic.co/fr/products/elasticsearch https://github.com/elastic/elasticsearch}
}
@article{Carpenter2004,
abstract = {The hypothesis we explored for the Ad Hoc task of the Genomics track for TREC 2004 was that phrase-level queries would increase precision over a baseline of token-level terms. We implemented our approach using two open source tools: the Apache Jakarta Lucene TF/IDF search engine (version 1.3) and the Alias-i LingPipe tokenizer and named-entity annotator (version 1.0.6). Contrary to our intuitions, the base-line system provided better performance in terms of recall and precision for almost every query at almost every precision/recall operating point. Thesis We hypothesized that including phrasal terms would improve precision of TREC-style ad hoc queries. To explore this hypothesis, we submitted two systems for the ad hoc query task of the genomics track of the 2004 TREC Conference. The first was a baseline system implementing standard TF/IDF-based search over a tokenized document collection. The second included quoted phrase-level queries extracted automatically using statistical models. Topics and Documents As with other ad hoc tasks in TREC, the input for evaluation was a list of topics of a fairly detailed variety. These were gathered from practicing research biologists and were meant to cover a range of topics. The first of the fifty used for the 2004 ad hoc genomics task is shown in Figure 1 (with line breaks inserted in place of some spaces and around XML text content segments for human readability).},
author = {Carpenter, Bob},
file = {:C$\backslash$:/Users/lb3/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Carpenter - 2004 - Phrasal Queries with LingPipe and Lucene Ad Hoc Genomics Text Retrieval.pdf:pdf},
journal = {TREC},
mendeley-groups = {DoMINO},
pages = {1--10},
title = {{Phrasal Queries with LingPipe and Lucene : Ad Hoc Genomics Text Retrieval}},
url = {https://pdfs.semanticscholar.org/647f/a3bd954266062195b3957ac54fe7b8d31cb7.pdf},
volume = {1},
year = {2004}
}
